Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Total 13F shares
-
27,456,300
-
Share change
-
-434,476
-
Total reported value
-
$191,708,869
-
Price per share
-
$6.98
-
Number of holders
-
99
-
Value change
-
-$3,337,860
-
Number of buys
-
48
-
Number of sells
-
46
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q3 2021
As of 30 Sep 2021 HARVARD BIOSCIENCE INC - Common Stock (HBIO) had 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,456,300 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Portolan Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., GRANAHAN INVESTMENT MANAGEMENT INC/MA, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and Harvey Partners, LLC.
This table shows 99 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.